Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

immunization

- PMLiVE

Lonza ends biosimilars deal with Teva

Chemical firm cuts losses after four-year development deal

CytomX makes senior changes following Pfizer deal

Krishna Polu joins as chief medical officer and Debanjan Ray promoted to VP, business development

Roche - Basel

New cancer drugs help drive Roche in first half

Perjeta, Kadcyla and Zelboraf support company growth

- PMLiVE

Pharma’s data sharing principles “weak and filled with loopholes”

Transparency campaigners attack EFPIA/ PhRMA commitment

- PMLiVE

Witty says Chinese bribery probe will impact GSK

CEO says company’s performance in China will be affected

Chiltern hires Roche’s Andrew Monaghan to head pharmacovigilance

He was global head of safety operations at pharma company

- PMLiVE

FDA panel fails to back new use for AbbVie’s Humira

Votes 12 to 1 against new use in spondyloarthritis

- PMLiVE

VIDEO: The potential of mHealth for pharma

PMLiVE speaks to Alexandra von Plato, president, global creative officer, Digitas Health at Think Digital 2013

- PMLiVE

Pharma industry announces data sharing commitment

EFPIA and PhRMA agree to make trial info available to qualified researchers

Biogen Idec building

Patient death probably not linked to Biogen Idec’s Tecfidera

Stock recovers after unfounded claims

Roche - Basel

Roche antibody tops Rituxan in blood cancer CLL

Obinutuzumab on course for leukaemia approval by year-end

National Institute for Health and Care Excellence NICE logo

NICE gives final backing to drugs from Bayer, GSK and Otsuka

Eylea, Revolade and Abilify all recommended for NHS use

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links